Au-nanoprobes are efficiently applied to the direct detection of the molecular hallmark of chronic myeloid leukemia, BCR-ABL fusion transcripts, allowing the discrimination between the most frequent isoforms of this genetic abnormality, e13a2 and e14a2 [41]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.